IDEX stock kpis
Want to see IEX full AI Analyst Report?
Revenue By Segment
In Q3 2026, IDEX reported revenue by segment of -$1.20M (Eliminations), $327.90M (Fluid & Metering Technologies), $433.50M (Health & Science Technologies) and $191.50M (Fire & Safety/Diversified Products).
Analyzes revenue from different business segments, highlighting which areas are driving growth and which may need strategic adjustments.
Health & Science Technologies has become the growth engine—late-period acceleration and outsized order gains underpin management’s upward revision and higher targeted CapEx to scale capacity—while Fluid & Metering and Fire & Safety show only modest or choppy revenue gains with mix-driven margin pressure. The quarter’s margin lift was partly one‑time (IEEPA tariff refunds), so the key read-through is durable demand and backlog in HST driving 2026–27 upside, but watch FMT/FSDP mix risk and cyclical end‑market softness for downside to near‑term consistency.
IEX Revenue By Segment
| Period | Eliminations | Fluid & Metering Technologies | Health & Science Technologies | Fire & Safety/Diversified Products |
|---|---|---|---|---|
| Q3 2026Sep 30, 2026 | -$1.20M | $327.90M | $433.50M | $191.50M |
| Q2 2026Jun 30, 2026 | -$1.40M | $415.00M | $317.10M | $189.90M |
| Q1 2026Mar 31, 2026 | -$1.30M | $301.50M | $398.40M | $188.30M |
| Q4 2025Dec 31, 2025 | -$1.70M | $305.50M | $407.70M | $187.60M |
| Q3 2025Sep 30, 2025 | -$1.30M | $381.00M | $317.10M | $181.90M |
| Q2 2025Jun 30, 2025 | -$2.30M | $365.30M | $310.90M | $191.50M |
| Q1 2025Mar 31, 2025 | -$2.00M | $290.50M | $341.50M | $184.30M |
| Q4 2024Dec 31, 2024 | -$2.50M | $299.30M | $373.20M | $359.90M |
| Q3 2024Sep 30, 2024 | -$1.60M | $300.80M | $311.00M | $188.00M |
| Q2 2024Jun 30, 2024 | -$1.40M | $319.40M | $303.80M | $18.40M |
| Q1 2024Mar 31, 2024 | -$1.30M | $313.70M | $310.10M | $178.00M |
| Q4 2023Dec 31, 2023 | -$1.90M | $299.10M | $312.70M | $179.00M |
| Q3 2023Sep 30, 2023 | -$1.50M | $301.10M | $313.20M | $180.60M |
| Q2 2023Jun 30, 2023 | -$3.20M | $325.10M | $339.50M | $184.80M |
| Q1 2023Mar 31, 2023 | -$1.80M | $321.80M | $351.00M | $174.40M |
| Q4 2022Dec 31, 2022 | -$1.00M | $287.80M | $353.00M | $170.90M |
| Q3 2022Sep 30, 2022 | -$1.00M | $307.60M | $345.00M | $172.40M |
| Q2 2022Jun 30, 2022 | -$1.00M | $299.90M | $326.00M | $171.20M |
| Q1 2022Mar 31, 2022 | -$800.00K | $272.00M | $315.20M | $164.70M |
| Q4 2021Dec 31, 2021 | -$593.00K | $252.76M | $294.13M | $308.50M |
| Q3 2021Sep 30, 2021 | -$671.00K | $251.30M | $302.29M | $19.11M |
| Q2 2021Jun 30, 2021 | -$1.15M | $251.28M | $275.01M | $160.81M |
| Q1 2021Mar 31, 2021 | -$1.18M | $243.37M | $250.37M | $159.48M |

